Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis
Authors:
- Yuenian E. ShiYSYuenian E. Shi
Open Access
- 1 January 1991
- journal article
- Published by Elsevier in Preventive Medicine
- Vol. 20 (1) , 27-37
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesisPreventive Medicine, 1991
- Regulation of rat hepatocyte epidermal growth factor receptor by the liver tumor promoter ethinyl estradiolCarcinogenesis, 1990
- Enhancement in rats by the liver tumor promoter ethinyl estradiol of a serum factor(s) which is stimulatory for hepatocyte DNA synthesisBiochemical and Biophysical Research Communications, 1989
- Combined oral contraceptives and liver cancerInternational Journal of Cancer, 1989
- Non-genomic effects of estrogens and antiestrogensJournal of Steroid Biochemistry, 1988
- An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.Environmental Health Perspectives, 1987
- Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female ratsCarcinogenesis, 1986
- Assay of some endogenous and synthetic sex steroids for tumor-initiating activity in rat liver using the Solt-Farber systemCarcinogenesis, 1983
- Lack of hepatogenotoxicity of oral contraceptive steroidsCarcinogenesis, 1982